Neumora Therapeutics logo

Neumora Therapeutics

NMRA | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.01 (-2.64%)
At close: Nov 9, 2026, 4:00 PM ET
-2.64%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 9, 2026
33
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #725/1025 (Top 71%)

Key Statistics

Market Data

Market Cap $91.3M
1D Range
0.48 0.56
52W Range
0.35 3.59

Valuation (TTM)

PE -0.40
PB 2.05
EV/EBITDA 0.12

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $4.50
Loading financial charts...

Profile

Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerat...

Sector Healthcare
Industry Biotechnology
Employees 63
IPO Date Sep 15, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$4.50
Upside
+818.37%
Buy (6)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.